Open in App
  • Local
  • Headlines
  • Election
  • Sports
  • Lifestyle
  • Education
  • Real Estate
  • Newsletter
  • KOIN 6 News

    Report: Oregon Pharmacy Benefit Managers pass on less than 1% of drug rebates to enrollees

    By Jashayla Pettigrew,

    6 hours ago

    https://img.particlenews.com/image.php?url=4Py81W_0w2DeGi300

    PORTLAND, Ore. ( KOIN ) — Newly-uncovered data shows Oregonians benefitted from less than 1% of the drug rebates Pharmacy Benefit Managers collected in 2023.

    PBMs serve as intermediaries between medication manufacturers and consumers, determining which drugs are covered by health insurance and where prescriptions can be filled. With the passage of Senate Bill 192 , these third-party entities are now required to self-report the “aggregated amount of rebates, fees, price protection payments, and any other payments” manufacturers send.

    Wyden introduces bill banning lavish gifts for Supreme Court justices

    According to the data published by the Oregon Department of Financial Regulation , 18 PBMs received $287,583,732.64 in rebates and payments from manufacturers last year.

    A majority of the payments, $283,727,097.34, went to insurance companies — while $2,236,217.76 were passed on to consumers. The managers retained the remaining funds as revenue.

    However, Oregon State Pharmacy Association Executive Director Brian Mayo is suspicious of the self-reported data.

    Will Portland adopt rat birth control like New York, Boston? Expert weighs in

    “It is laughable we would take [PBMs] own word for it,” Mayo wrote in an email. “Are we expected to believe that a PBM, regularly posting $1.3+ Billion in quarterly, is passing through all but less than 1% of their profit back to patients? Patients at Oregon’s pharmacy windows would be taken aback by this insult to their intelligence.”

    The executive director added patients have experienced an uptick in drug costs and a decline in access to local pharmacies. The House Committee on Oversight and Accountability noted similar points this July, when they revealed a report on the nation’s three largest PBMs that have been accused of hindering consumers and pharmacies with “deliberate, anticompetitive policies.”

    Additionally, an audit the Oregon Secretary of State’s office released in August 2023 — before SB 192 went into effect — determined health officials weren’t ensuring “sufficient transparency and compliance” from PBMs.

    Oregon health providers urge caution in using new blood test for colon cancer

    According to Mayo, the findings from state and national officials show “PBMs are siphoning off profits and protecting their assets in tax-free, off-shore accounts, jeopardizing patient care and patient safety without regard.”

    The recent data does not include payment details for public insurance programs like Medicare or the Oregon Health Plan.

    Copyright 2024 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

    For the latest news, weather, sports, and streaming video, head to KOIN.com.

    Expand All
    Comments / 1
    Add a Comment
    real_snoopster
    5h ago
    so the Democrats put a lot into effect that they must self-report, then they do self report and then you complain that you don't trust their numbers. well if you didn't trust their numbers why did you ask them to do it in the first place your bunch of morons? also, who's to say that those price decreases went directly to drug prices? Guess what they didn't, they went to the premiums which were lowered. The prices that people pay at the window or negotiated by the employers with the PPMs. this article is bogus and pathetic
    View all comments
    YOU MAY ALSO LIKE
    Local News newsLocal News
    Alameda Post16 days ago

    Comments / 0